• LENSAR appointed Michael A. Rossi as interim chief financial officer, effective May 29, 2026.
• Rossi previously served as CFO of Access Vascular, ConcertAI, and Harvard Bioscience.
• He has experience in healthcare turnarounds, operational improvements, strategic acquisitions, and liquidity management.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LENSAR Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-248230), on May 29, 2026, and is solely responsible for the information contained therein.